Skip to main content
NYSEARCA:IBDS

iShares iBonds Dec 2027 Term Corporate ETF Stock Forecast, Price & News

$26.93
+0.08 (+0.30 %)
(As of 05/13/2021 12:00 AM ET)
Add
Today's Range
$26.90
$27.07
50-Day Range
$26.65
$27.01
52-Week Range
$25.63
$27.78
Volume131,373 shs
Average Volume69,393 shs
Market Capitalization$448.38 million
P/E RatioN/A
Dividend Yield2.49%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IBDS News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares iBonds Dec 2027 Term Corporate ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares iBonds Dec 2027 Term Corporate ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IBDS
Inception Date9/12/2017
Fund ManagerJames Mauro, Scott Radell
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
BenchmarkBarclays December 2027 Maturity Corporate Index
CategoryCorporate
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$447.73 million
Average Daily Volume$57,233.00
Discount/Premium0.04%

ETF Expenses

Management Fee0.10%
Other Expenses0.00%
Total Expenses0.10%
Fee Waiver0.00%
Net Expenses0.10%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of IBDS

Currency Exposure of IBDS

Sector Exposure of IBDS

Industry Exposure of IBDS

speech bubbles
speech bubbles











iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS) Frequently Asked Questions

What stocks does MarketBeat like better than iShares iBonds Dec 2027 Term Corporate ETF?

Wall Street analysts have given iShares iBonds Dec 2027 Term Corporate ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares iBonds Dec 2027 Term Corporate ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares iBonds Dec 2027 Term Corporate ETF's stock price been impacted by COVID-19 (Coronavirus)?

iShares iBonds Dec 2027 Term Corporate ETF's stock was trading at $25.40 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IBDS stock has increased by 6.0% and is now trading at $26.93.
View which stocks have been most impacted by COVID-19
.

Is iShares iBonds Dec 2027 Term Corporate ETF a good dividend stock?

iShares iBonds Dec 2027 Term Corporate ETF pays an annual dividend of $0.67 per share and currently has a dividend yield of 2.49%.
View iShares iBonds Dec 2027 Term Corporate ETF's dividend history.

What other stocks do shareholders of iShares iBonds Dec 2027 Term Corporate ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares iBonds Dec 2027 Term Corporate ETF investors own include CenterPoint Energy (CNP), Chevron (CVX), Eagle Point Credit (ECC), Ford Motor (F), General Electric (GE), SPDR S&P Global Natural Resources ETF (GNR), iShares S&P 400 MidCap ETF (IJH), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and L Brands (LB).

What is iShares iBonds Dec 2027 Term Corporate ETF's stock symbol?

iShares iBonds Dec 2027 Term Corporate ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IBDS."

Who are iShares iBonds Dec 2027 Term Corporate ETF's major shareholders?

iShares iBonds Dec 2027 Term Corporate ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Capital Investment Advisors LLC (3.19%), Confluence Investment Management LLC (2.60%), US Bancorp DE (1.51%), Sandy Spring Bank (1.06%), Janney Montgomery Scott LLC (0.99%) and Praetorian Wealth Management Inc. (0.46%).

Which institutional investors are selling iShares iBonds Dec 2027 Term Corporate ETF stock?

IBDS stock was sold by a variety of institutional investors in the last quarter, including Sandy Spring Bank, Timber Creek Capital Management LLC, and Asset Dedication LLC.

Which institutional investors are buying iShares iBonds Dec 2027 Term Corporate ETF stock?

IBDS stock was purchased by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Archford Capital Strategies LLC, Praetorian Wealth Management Inc., RVW Wealth LLC, Janney Montgomery Scott LLC, Confluence Investment Management LLC, Bank of New York Mellon Corp, and Cambridge Investment Research Advisors Inc..

How do I buy shares of iShares iBonds Dec 2027 Term Corporate ETF?

Shares of IBDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares iBonds Dec 2027 Term Corporate ETF's stock price today?

One share of IBDS stock can currently be purchased for approximately $26.93.

How much money does iShares iBonds Dec 2027 Term Corporate ETF make?

iShares iBonds Dec 2027 Term Corporate ETF has a market capitalization of $448.38 million.


This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.